ReP USP - Resultado da busca

Artigo de periodico-carta/editorial
Therapeutic potential of flavonoid derivatives for certain neglected tropical diseases [Editorial] (2022)
Pone, Boniface Kamdem ; Ferreira, Elizabeth Igne
Source: Current Drug Targets. Unidade: FCF
Subjects: FLAVONOIDES, MEDICAMENTO, DOENÇAS NEGLIGENCIADAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PONE, Boniface Kamdem e FERREIRA, Elizabeth Igne. Therapeutic potential of flavonoid derivatives for certain neglected tropical diseases [Editorial]. Current Drug Targets. Sharjah: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. Disponível em: https://doi.org/10.2174/1389450123666220309093827. Acesso em: 28 maio 2024. , 2022
APA
Pone, B. K., & Ferreira, E. I. (2022). Therapeutic potential of flavonoid derivatives for certain neglected tropical diseases [Editorial]. Current Drug Targets. Sharjah: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. doi:10.2174/1389450123666220309093827
NLM
Pone BK, Ferreira EI. Therapeutic potential of flavonoid derivatives for certain neglected tropical diseases [Editorial] [Internet]. Current Drug Targets. 2022 ; 23( 7): 680-682.[citado 2024 maio 28 ] Available from: https://doi.org/10.2174/1389450123666220309093827
Vancouver
Pone BK, Ferreira EI. Therapeutic potential of flavonoid derivatives for certain neglected tropical diseases [Editorial] [Internet]. Current Drug Targets. 2022 ; 23( 7): 680-682.[citado 2024 maio 28 ] Available from: https://doi.org/10.2174/1389450123666220309093827
Artigo de periodico
Triazole-containing heterocycles: privileged scaffolds in anti-Trypanosoma cruzi drug development (2022)
Pone, Kamdem Boniface ; Dalhatou, Sadou; Paumo, Hugues Kamdem ; Seru, Lebogang Maureen Katata ; Ferreira, Elizabeth Igne
Source: Current Drug Targets. Unidade: FCF
Subjects: TRYPANOSOMA CRUZI, COMPOSTOS HETEROCÍCLICOS, ANTIPROTOZOÁRIOS, DOENÇAS NEGLIGENCIADAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PONE, Kamdem Boniface et al. Triazole-containing heterocycles: privileged scaffolds in anti-Trypanosoma cruzi drug development. Current Drug Targets, v. 23, n. 1, p. 33-59, 2022Tradução . . Disponível em: https://doi.org/10.2174/1389450122666210412125643. Acesso em: 28 maio 2024.
APA
Pone, K. B., Dalhatou, S., Paumo, H. K., Seru, L. M. K., & Ferreira, E. I. (2022). Triazole-containing heterocycles: privileged scaffolds in anti-Trypanosoma cruzi drug development. Current Drug Targets, 23( 1), 33-59. doi:10.2174/1389450122666210412125643
NLM
Pone KB, Dalhatou S, Paumo HK, Seru LMK, Ferreira EI. Triazole-containing heterocycles: privileged scaffolds in anti-Trypanosoma cruzi drug development [Internet]. Current Drug Targets. 2022 ; 23( 1): 33-59.[citado 2024 maio 28 ] Available from: https://doi.org/10.2174/1389450122666210412125643
Vancouver
Pone KB, Dalhatou S, Paumo HK, Seru LMK, Ferreira EI. Triazole-containing heterocycles: privileged scaffolds in anti-Trypanosoma cruzi drug development [Internet]. Current Drug Targets. 2022 ; 23( 1): 33-59.[citado 2024 maio 28 ] Available from: https://doi.org/10.2174/1389450122666210412125643
Artigo de periodico
The role of nitro (NO 2-), Chloro (Cl), and Fluoro (F) substitution in the design of antileishmanial and antichagasic compounds (2021)
Boniface, Pone Kamdem ; Ferreira, Elizabeth Igne
Source: Current Drug Targets. Unidade: FCF
Subjects: DOENÇAS NEGLIGENCIADAS, ANTIMALÁRICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BONIFACE, Pone Kamdem e FERREIRA, Elizabeth Igne. The role of nitro (NO 2-), Chloro (Cl), and Fluoro (F) substitution in the design of antileishmanial and antichagasic compounds. Current Drug Targets, v. 22, p. 379-398, 2021Tradução . . Disponível em: https://doi.org/10.2174/1389450121666201228122239. Acesso em: 28 maio 2024.
APA
Boniface, P. K., & Ferreira, E. I. (2021). The role of nitro (NO 2-), Chloro (Cl), and Fluoro (F) substitution in the design of antileishmanial and antichagasic compounds. Current Drug Targets, 22, 379-398. doi:10.2174/1389450121666201228122239
NLM
Boniface PK, Ferreira EI. The role of nitro (NO 2-), Chloro (Cl), and Fluoro (F) substitution in the design of antileishmanial and antichagasic compounds [Internet]. Current Drug Targets. 2021 ; 22 379-398.[citado 2024 maio 28 ] Available from: https://doi.org/10.2174/1389450121666201228122239
Vancouver
Boniface PK, Ferreira EI. The role of nitro (NO 2-), Chloro (Cl), and Fluoro (F) substitution in the design of antileishmanial and antichagasic compounds [Internet]. Current Drug Targets. 2021 ; 22 379-398.[citado 2024 maio 28 ] Available from: https://doi.org/10.2174/1389450121666201228122239
Artigo de periodico
Design of novel phosphopantetheine adenylyltransferase inhibitors: a potential new approach to tackle Mycobacterium tuberculosis (2021)
Primi, Marina Candido ; Tavares, Maurício Temotheo ; Klein, Larry L; Izard, Tina; Sant'Anna, Carlos M. R; Franzblau, Scott Gary; Ferreira, Elizabeth Igne
Source: Current Topics in Medicinal Chemistry. Unidade: FCF
Subjects: TUBERCULOSE, ANTIBIÓTICOS, INIBIDORES DE ENZIMAS, QUIMIOTERAPIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PRIMI, Marina Candido et al. Design of novel phosphopantetheine adenylyltransferase inhibitors: a potential new approach to tackle Mycobacterium tuberculosis. Current Topics in Medicinal Chemistry, v. 21, p. 1186-1197, 2021Tradução . . Disponível em: https://doi.org/10.2174/1568026621666210728094804. Acesso em: 28 maio 2024.
APA
Primi, M. C., Tavares, M. T., Klein, L. L., Izard, T., Sant'Anna, C. M. R., Franzblau, S. G., & Ferreira, E. I. (2021). Design of novel phosphopantetheine adenylyltransferase inhibitors: a potential new approach to tackle Mycobacterium tuberculosis. Current Topics in Medicinal Chemistry, 21, 1186-1197. doi:10.2174/1568026621666210728094804
NLM
Primi MC, Tavares MT, Klein LL, Izard T, Sant'Anna CMR, Franzblau SG, Ferreira EI. Design of novel phosphopantetheine adenylyltransferase inhibitors: a potential new approach to tackle Mycobacterium tuberculosis [Internet]. Current Topics in Medicinal Chemistry. 2021 ; 21 1186-1197.[citado 2024 maio 28 ] Available from: https://doi.org/10.2174/1568026621666210728094804
Vancouver
Primi MC, Tavares MT, Klein LL, Izard T, Sant'Anna CMR, Franzblau SG, Ferreira EI. Design of novel phosphopantetheine adenylyltransferase inhibitors: a potential new approach to tackle Mycobacterium tuberculosis [Internet]. Current Topics in Medicinal Chemistry. 2021 ; 21 1186-1197.[citado 2024 maio 28 ] Available from: https://doi.org/10.2174/1568026621666210728094804
Artigo de periodico
An insight into the discovery of potent Antifilarial leads against lymphatic filariasis (2020)
Boniface, Pone Kamdem ; Ferreira, Elizabeth Igne
Source: Current Drug Targets. Unidade: FCF
Subjects: FILARIOSE, DOENÇAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BONIFACE, Pone Kamdem e FERREIRA, Elizabeth Igne. An insight into the discovery of potent Antifilarial leads against lymphatic filariasis. Current Drug Targets, v. 21, p. 657-680, 2020Tradução . . Disponível em: https://doi.org/10.2174/1389450120666191204152415. Acesso em: 28 maio 2024.
APA
Boniface, P. K., & Ferreira, E. I. (2020). An insight into the discovery of potent Antifilarial leads against lymphatic filariasis. Current Drug Targets, 21, 657-680. doi:10.2174/1389450120666191204152415
NLM
Boniface PK, Ferreira EI. An insight into the discovery of potent Antifilarial leads against lymphatic filariasis [Internet]. Current Drug Targets. 2020 ; 21 657-680.[citado 2024 maio 28 ] Available from: https://doi.org/10.2174/1389450120666191204152415
Vancouver
Boniface PK, Ferreira EI. An insight into the discovery of potent Antifilarial leads against lymphatic filariasis [Internet]. Current Drug Targets. 2020 ; 21 657-680.[citado 2024 maio 28 ] Available from: https://doi.org/10.2174/1389450120666191204152415
Artigo de periodico
Unveiling the targets involved in the quest of antileishmanial Leads using in silico methods (2020)
Boniface, Pone Kamdem ; Sano, Cinthya Miyuki; Ferreira, Elizabeth Igne
Source: Current Drug Targets. Unidade: FCF
Subjects: LEISHMANIA, FARMACOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BONIFACE, Pone Kamdem e SANO, Cinthya Miyuki e FERREIRA, Elizabeth Igne. Unveiling the targets involved in the quest of antileishmanial Leads using in silico methods. Current Drug Targets, v. 21, p. 681-712, 2020Tradução . . Disponível em: https://doi.org/10.2174/1389450121666200128112948. Acesso em: 28 maio 2024.
APA
Boniface, P. K., Sano, C. M., & Ferreira, E. I. (2020). Unveiling the targets involved in the quest of antileishmanial Leads using in silico methods. Current Drug Targets, 21, 681-712. doi:10.2174/1389450121666200128112948
NLM
Boniface PK, Sano CM, Ferreira EI. Unveiling the targets involved in the quest of antileishmanial Leads using in silico methods [Internet]. Current Drug Targets. 2020 ; 21 681-712.[citado 2024 maio 28 ] Available from: https://doi.org/10.2174/1389450121666200128112948
Vancouver
Boniface PK, Sano CM, Ferreira EI. Unveiling the targets involved in the quest of antileishmanial Leads using in silico methods [Internet]. Current Drug Targets. 2020 ; 21 681-712.[citado 2024 maio 28 ] Available from: https://doi.org/10.2174/1389450121666200128112948
Artigo de periodico-carta/editorial
Drug design and development for neglected diseases [Editorial] (2019)
Ferreira, Elizabeth Igne
Source: Current Medicinal Chemistry. Unidade: FCF
Assunto: DOENÇAS NEGLIGENCIADAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FERREIRA, Elizabeth Igne. Drug design and development for neglected diseases [Editorial]. Current Medicinal Chemistry. Sharjah: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. Disponível em: https://doi.org/10.2174/092986732623190927101548. Acesso em: 28 maio 2024. , 2019
APA
Ferreira, E. I. (2019). Drug design and development for neglected diseases [Editorial]. Current Medicinal Chemistry. Sharjah: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. doi:10.2174/092986732623190927101548
NLM
Ferreira EI. Drug design and development for neglected diseases [Editorial] [Internet]. Current Medicinal Chemistry. 2019 ; 26( 23): 4298-4300.[citado 2024 maio 28 ] Available from: https://doi.org/10.2174/092986732623190927101548
Vancouver
Ferreira EI. Drug design and development for neglected diseases [Editorial] [Internet]. Current Medicinal Chemistry. 2019 ; 26( 23): 4298-4300.[citado 2024 maio 28 ] Available from: https://doi.org/10.2174/092986732623190927101548
Artigo de periodico
Drug design for neglected disease in Brazil (2015)
Giarolla, Jeanine ; Ferreira, Elizabeth Igne
Source: Mini Reviews in Medicinal Chemistry. Unidade: FCF
Subjects: DOENÇA DE CHAGAS, LEISHMANIA, MALÁRIA, TUBERCULOSE, DOENÇAS NEGLIGENCIADAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GIAROLLA, Jeanine e FERREIRA, Elizabeth Igne. Drug design for neglected disease in Brazil. Mini Reviews in Medicinal Chemistry, v. 15, n. 3, p. 220-242, 2015Tradução . . Acesso em: 28 maio 2024.
APA
Giarolla, J., & Ferreira, E. I. (2015). Drug design for neglected disease in Brazil. Mini Reviews in Medicinal Chemistry, 15( 3), 220-242.
NLM
Giarolla J, Ferreira EI. Drug design for neglected disease in Brazil. Mini Reviews in Medicinal Chemistry. 2015 ; 15( 3): 220-242.[citado 2024 maio 28 ]
Vancouver
Giarolla J, Ferreira EI. Drug design for neglected disease in Brazil. Mini Reviews in Medicinal Chemistry. 2015 ; 15( 3): 220-242.[citado 2024 maio 28 ]
Artigo de periodico
New tuberculostatic agents targeting nucleic acid biosynthesis: drug design using QSAR approaches (2014)
Bueno, Renata Vieria; Braga, Rodolpho de Campos; Segretti, Natanael Dante; Ferreira, Elizabeth Igne ; Trossini, Gustavo Henrique Goulart ; Andrade, Carolina Horta
Source: Current Pharmaceutical Design. Unidade: FCF
Subjects: TUBERCULOSE, ÁCIDOS NUCLEICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BUENO, Renata Vieria et al. New tuberculostatic agents targeting nucleic acid biosynthesis: drug design using QSAR approaches. Current Pharmaceutical Design, v. 20, n. 27, p. 4474-4485, 2014Tradução . . Acesso em: 28 maio 2024.
APA
Bueno, R. V., Braga, R. de C., Segretti, N. D., Ferreira, E. I., Trossini, G. H. G., & Andrade, C. H. (2014). New tuberculostatic agents targeting nucleic acid biosynthesis: drug design using QSAR approaches. Current Pharmaceutical Design, 20( 27), 4474-4485.
NLM
Bueno RV, Braga R de C, Segretti ND, Ferreira EI, Trossini GHG, Andrade CH. New tuberculostatic agents targeting nucleic acid biosynthesis: drug design using QSAR approaches. Current Pharmaceutical Design. 2014 ; 20( 27): 4474-4485.[citado 2024 maio 28 ]
Vancouver
Bueno RV, Braga R de C, Segretti ND, Ferreira EI, Trossini GHG, Andrade CH. New tuberculostatic agents targeting nucleic acid biosynthesis: drug design using QSAR approaches. Current Pharmaceutical Design. 2014 ; 20( 27): 4474-4485.[citado 2024 maio 28 ]
Artigo de periodico
Nitric oxide: State of the art in drug design (2012)
Serafim, Ricardo Augusto Massarico; Primi, Marina Candido; Trossini, Gustavo Henrique Goulart ; Ferreira, Elizabeth Igne
Source: Current Medicinal Chemistry. Unidade: FCF
Subjects: ANTI-INFLAMATÓRIOS NÃO ESTEROIDES, ÓXIDO NÍTRICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SERAFIM, Ricardo Augusto Massarico et al. Nitric oxide: State of the art in drug design. Current Medicinal Chemistry, v. 19, n. 3, p. 386-405, 2012Tradução . . Disponível em: https://doi.org/10.2174/092986712803414321. Acesso em: 28 maio 2024.
APA
Serafim, R. A. M., Primi, M. C., Trossini, G. H. G., & Ferreira, E. I. (2012). Nitric oxide: State of the art in drug design. Current Medicinal Chemistry, 19( 3), 386-405. doi:10.2174/092986712803414321
NLM
Serafim RAM, Primi MC, Trossini GHG, Ferreira EI. Nitric oxide: State of the art in drug design [Internet]. Current Medicinal Chemistry. 2012 ; 19( 3): 386-405.[citado 2024 maio 28 ] Available from: https://doi.org/10.2174/092986712803414321
Vancouver
Serafim RAM, Primi MC, Trossini GHG, Ferreira EI. Nitric oxide: State of the art in drug design [Internet]. Current Medicinal Chemistry. 2012 ; 19( 3): 386-405.[citado 2024 maio 28 ] Available from: https://doi.org/10.2174/092986712803414321
Artigo de periodico
Molecular modeling suggests cruzain specificity for peptide primaquine prodrugs (2010)
Trossini, Gustavo Henrique Goulart ; Chin, Chung Man; Menezes, Carla Maria de Souza; Ferreira, Elizabeth Igne
Source: Letters in Drug Design & Discovery. Unidade: FCF
Subjects: DOENÇA DE CHAGAS, TRYPANOSOMA CRUZI, PROTEINASES, MODELAGEM MOLECULAR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TROSSINI, Gustavo Henrique Goulart et al. Molecular modeling suggests cruzain specificity for peptide primaquine prodrugs. Letters in Drug Design & Discovery, v. 7, n. 7, p. 528-533, 2010Tradução . . Disponível em: https://doi.org/10.2174/157018010791526287. Acesso em: 28 maio 2024.
APA
Trossini, G. H. G., Chin, C. M., Menezes, C. M. de S., & Ferreira, E. I. (2010). Molecular modeling suggests cruzain specificity for peptide primaquine prodrugs. Letters in Drug Design & Discovery, 7( 7), 528-533. doi:10.2174/157018010791526287
NLM
Trossini GHG, Chin CM, Menezes CM de S, Ferreira EI. Molecular modeling suggests cruzain specificity for peptide primaquine prodrugs [Internet]. Letters in Drug Design & Discovery. 2010 ; 7( 7): 528-533.[citado 2024 maio 28 ] Available from: https://doi.org/10.2174/157018010791526287
Vancouver
Trossini GHG, Chin CM, Menezes CM de S, Ferreira EI. Molecular modeling suggests cruzain specificity for peptide primaquine prodrugs [Internet]. Letters in Drug Design & Discovery. 2010 ; 7( 7): 528-533.[citado 2024 maio 28 ] Available from: https://doi.org/10.2174/157018010791526287
Artigo de periodico
Tree-dimensional quantitative structure-activity relationships for a large series of potent antitubercular agents (2008)
Andrade, Carolina Horta; Salum, Lívia de Barros; Pasqualoto, Kerly Fernanda Mesquita; Ferreira, Elizabeth Igne ; Andricopulo, Adriano Defini
Source: Letters in Drug Design and Discovery. Unidades: FCF, IFSC
Subjects: FÁRMACOS, PLANEJAMENTO DE FÁRMACOS, TUBERCULOSE, DOENÇAS (TRATAMENTO), RELAÇÕES ESTRUTURA-ATIVIDADE, RELAÇÕES QUANTITATIVAS ENTRE ESTRUTURA QUÍMICA E ATIVIDADE BIOLÓGICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ANDRADE, Carolina Horta et al. Tree-dimensional quantitative structure-activity relationships for a large series of potent antitubercular agents. Letters in Drug Design and Discovery, v. 5, n. 6, p. 377-387, 2008Tradução . . Disponível em: https://doi.org/10.2174/157018008785777289. Acesso em: 28 maio 2024.
APA
Andrade, C. H., Salum, L. de B., Pasqualoto, K. F. M., Ferreira, E. I., & Andricopulo, A. D. (2008). Tree-dimensional quantitative structure-activity relationships for a large series of potent antitubercular agents. Letters in Drug Design and Discovery, 5( 6), 377-387. doi:10.2174/157018008785777289
NLM
Andrade CH, Salum L de B, Pasqualoto KFM, Ferreira EI, Andricopulo AD. Tree-dimensional quantitative structure-activity relationships for a large series of potent antitubercular agents [Internet]. Letters in Drug Design and Discovery. 2008 ; 5( 6): 377-387.[citado 2024 maio 28 ] Available from: https://doi.org/10.2174/157018008785777289
Vancouver
Andrade CH, Salum L de B, Pasqualoto KFM, Ferreira EI, Andricopulo AD. Tree-dimensional quantitative structure-activity relationships for a large series of potent antitubercular agents [Internet]. Letters in Drug Design and Discovery. 2008 ; 5( 6): 377-387.[citado 2024 maio 28 ] Available from: https://doi.org/10.2174/157018008785777289

USP Schools

ReP

Filtros

Authors

Date published

Subjects

Source title

Non normalized affiliation